Clinical Trials Logo

Clinical Trial Summary

Rising thyroid carcinoma rates, with papillary thyroid carcinoma (PTC) as the main type (85-90% of cases), often show early cervical lymph node spread. This increases the risk of PTC patients for recurrence and death. A new study's multimodal model fuses preoperative US and cytology images to better predict lymph node metastasis, aiming to improve treatment plans, reduce unnecessary surgeries, and enhance patient outcomes.


Clinical Trial Description

Thyroid carcinoma incidence has been on the rise in recent years. Papillary thyroid carcinoma is the most prevalent type of differentiated thyroid carcinoma, accounting for 85% to 90% of malignant thyroid tumors. Despite its indolent nature, cervical lymph node metastasis is frequently observed at an early stage. Papillary thyroid carcinoma patients with cervical lymph node metastasis face an elevated risk of recurrence, distant metastasis, and mortality. Thus, non-invasive preoperative prediction of cervical lymph node metastasis is particularly vital for guiding treatment plans and prognostic. this study has developed a multimodal model integrating preoperative US images with cytological images of papillary thyroid carcinoma patients. The aim is to enhance the predictive accuracy for cervical lymph node metastasis, reduce unnecessary lymph node dissections, and provide real-time, precise guidance for determining the extent of surgical resection and prognostic assessment. This approach aims to optimize patient treatment strategies and enhance therapeutic outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06399159
Study type Observational
Source Nanchong Central Hospital
Contact
Status Completed
Phase
Start date September 1, 2023
Completion date April 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06065891 - Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer N/A
Recruiting NCT06135571 - Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
Completed NCT06439745 - More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated
Completed NCT00964977 - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis. Phase 3
Completed NCT04233476 - 99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer Phase 3
Enrolling by invitation NCT06048146 - A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis N/A
Recruiting NCT05720598 - Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer N/A
Recruiting NCT05970913 - PET-CT Predicting Segement Specific Lymph Nodes Metastasis
Recruiting NCT02142244 - Fluorescence Surgery for Sentinel Node Identification in Melanoma N/A
Enrolling by invitation NCT06273501 - MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer N/A
Completed NCT02704988 - Clinical Trial Comparing Carnoy's and GEWF Solutions N/A
Completed NCT06401590 - Sensitivity and Predictive Value of Frozen Section of Sentinel Lymph Node Biopsy in Post Neoadjuvant Setting
Not yet recruiting NCT06264167 - NODE (groiN ultrasOunD cancEr) N/A
Recruiting NCT03588416 - Multicentric Study About Pathological Risk Factors for Lymph Node Metastasis in Malignant Colorectal Polyps
Not yet recruiting NCT06435741 - Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe. N/A
Recruiting NCT05754814 - SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
Not yet recruiting NCT05375526 - Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer N/A
Completed NCT05867095 - Navigated Abdominal Lymph Node Dissections N/A
Not yet recruiting NCT05336643 - Radioisotope and Fluorescence Guidance in Rectal Cancer N/A
Recruiting NCT05573451 - Comparison of the Accuracy of US, MRI and PET/CT in the Assessment of LNs in Cervical Cancer.